Eric J. Daniels's most recent trade in Cerenome Inc. was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cerenome Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Cerenome Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.95 per share. | 01 Apr 2026 | 929 | 31,741 (0%) | 0% | 2.0 | 1,812 | Common Stock |
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 13,067 | 13,067 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 6,533 | 32,670 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 01 Apr 2025 | 15,543 | 15,543 | - | - | Stock Option (right to buy) | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 01 Apr 2025 | 7,772 | 26,375 (0%) | 0% | 0 | Common Stock | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 01 Jul 2024 | 14,710 | 14,710 | - | - | Stock Option (right to buy) | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 01 Jul 2024 | 7,355 | 18,577 (0%) | 0% | 0 | Common Stock | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 14 Jun 2024 | 1,431 | 11,222 (0%) | 0% | 5.3 | 7,570 | Common Stock | |
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 03 Mar 2023 | 15,600 | 25,838 (0%) | 0% | 0 | Common Stock | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 03 Mar 2023 | 10,400 | 10,400 | - | - | Stock Option (right to buy) | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 21 Oct 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 21 Oct 2022 | 10,000 | 10,238 (0%) | 0% | 0 | Common Stock | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 01 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
| Kiora Pharma Inc | Eric J. Daniels | Chief Development Officer | 21 Oct 2021 | 9,520 | 9,520 (0%) | 0% | - | Common Stock |